Cargando…
Mitochondrial D310 mutation as clonal marker for solid tumors
Patients with multiple tumors, either synchronous or metachronous, can have metastatic disease or suffer from multiple independent primary tumors. While proper diagnosis of these patients is important for prognosis and treatment, this can be challenging using only clinical and histological criteria....
Autores principales: | Geurts-Giele, Willemina R. R., Gathier, Gerard H. G. K., Atmodimedjo, Peggy N., Dubbink, Hendrikus J., Dinjens, Winand N. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656708/ https://www.ncbi.nlm.nih.gov/pubmed/26276353 http://dx.doi.org/10.1007/s00428-015-1817-5 |
Ejemplares similares
-
Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers
por: Eikenboom, Ellis L., et al.
Publicado: (2021) -
Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome
por: Geurts‐Giele, Willemina R., et al.
Publicado: (2019) -
Unexplained mismatch repair deficiency: Case closed
por: Eikenboom, Ellis L., et al.
Publicado: (2022) -
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
por: Synhaeve, Nathalie E., et al.
Publicado: (2018) -
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
por: Wijnenga, Maarten M. J., et al.
Publicado: (2018)